Regenerative & pain

What Is Exosome Therapy for the Face?

“Exosome facials” are one of the most-searched new skin procedures. Here is what goes into one, what the early studies show, and what the FDA has and has not approved.

Short answer

Exosome therapy for the face usually means applying a liquid that contains exosomes, tiny packages released by cells, to the skin right after microneedling or a laser has opened small channels in it. Small early studies report short-term gains in hydration, elasticity and overall appearance, but most are short and many are not randomized (Flores Rodríguez et al., 2026). No exosome product is FDA-approved, for the face or for any other use (U.S. Food and Drug Administration [FDA], 2019).

What this means

Exosomes are microscopic, membrane-wrapped packages that cells release to signal to one another. They carry proteins, fats and genetic material, but they are not cells and contain nothing alive. Products sold for skin procedures are most often made from human stem cells grown in a lab, commonly from fat or umbilical cord tissue. Some are plant-derived instead (Huang et al., 2026).

“Exosome facial” is not one standardized procedure. Products differ in their source, concentration and manufacturing, and a result reported with one product does not automatically apply to another. The FDA regulates exosomes used for medical conditions as drugs and biological products, and it states there are currently no FDA-approved exosome products (FDA, 2019).

Candidacy

There is no FDA-defined candidate for an investigational skin procedure. People who ask about exosomes for the face are usually interested in fine lines, dullness, uneven texture, enlarged pores or acne scarring, or want support for the skin after microneedling or a laser procedure.

It is usually better to wait, or to choose something else, if you have an active skin infection or cold sore, a flare of acne in the area, a history of keloid scarring, known allergies to product ingredients, or are pregnant or breastfeeding, since there is no safety data for these groups. If you want the option with the strongest evidence behind it, an established approach is usually the better starting point.

Clinical evaluation

Before any skin procedure, Dr. Chantasi looks at:

  • The main concern. Wrinkles, sun spots, scarring and loose skin respond to different things, so naming the goal comes first.
  • Skin type and history. Cold sores, keloids, eczema, and past reactions to procedures or products.
  • Medications and skincare. Prescription retinoids, recent isotretinoin, blood thinners and anything that makes the skin more sensitive.
  • The product itself. Its source, its manufacturer and its FDA status, all given to you in writing.
  • Your goals and timeline. What you hope to see, and how much downtime and cost make sense for you.

Available options

The mainstream options for aging or sun-damaged facial skin, as described by the American Academy of Dermatology, include moisturizer, a prescription retinoid applied to the skin, chemical peels, microdermabrasion, laser resurfacing, injectable fillers and Botox. Daily sun protection underpins all of them (American Academy of Dermatology [AAD], 2025). Fillers and neuromodulators such as Botox Cosmetic are FDA-approved for specific uses, which a licensed provider can explain for your face.

At PrimeCell, options include medical microneedling, PRP or PRF from your own blood, barrier-first Korean-inspired skin care, neuromodulators, and fillers or collagen stimulators. In selected cases, after an evaluation and written informed consent, Dr. Chantasi may use an exosome product, alone or with microneedling or PRP. How each is approached is described on the regenerative aesthetics page.

Benefits, limitations and risks

In small studies, people who received exosome products with microneedling, lasers or other delivery methods showed short-term improvements in skin hydration, elasticity, wrinkles, pores, pigmentation and overall appearance (Flores Rodríguez et al., 2026). The session itself is usually short, and most downtime comes from the microneedling or laser it is paired with.

The limitations are real. The studies are small, short and use different products, so it is hard to predict what one specific product will do for you. These procedures are self-pay, may involve several sessions, and results vary from person to person.

Microneedling itself commonly causes temporary redness and swelling, and any procedure that opens the skin carries a risk of infection or an allergic or irritant reaction. A systematic review noted individual reports of problems when exosome products were injected off-label rather than applied to the skin (Flores Rodríguez et al., 2026). The FDA has also reported serious adverse events in patients who received unapproved products marketed as containing exosomes (FDA, 2019), and it has received reports of infections, blindness and tumor formation from unapproved regenerative products more broadly (FDA, 2021). Long-term safety is not yet known (Dhaliwal et al., 2026).

What the evidence shows

What it establishes: In a randomized split-face trial of 16 adults aged 40 and older, the side of the face that received a solution containing exosomes from human fat-derived stem cells, in three sessions two weeks apart, showed better hydration, barrier function and elasticity than the side that received saline over eight weeks. No significant adverse events were seen (Choi et al., 2026).

A systematic review of 19 human studies found exosome-based procedures were associated with short-term improvements in skin quality, but most of the studies were not randomized and follow-up was limited (Flores Rodríguez et al., 2026). A second review, focused on microneedling with exosomes, found only eight eligible studies, ranging from 3 to 60 participants, and concluded that more evidence is needed on both safety and effectiveness (Dhaliwal et al., 2026).

What it does not establish: that results last beyond a few months, that one exosome product performs like another, or that exosomes outperform established options such as prescription retinoids or laser resurfacing. Long-term safety is also unknown. Larger, longer trials with standardized products are still needed.

Recovery and next steps

Recovery depends mostly on the procedure the exosome product is paired with. After microneedling, skin is often pink and tight for a short time, and you will receive written aftercare covering cleansing, moisturizing, sun protection and when to restart active skincare. Call the office for spreading redness, pus, fever, blistering or severe pain.

If you are weighing an exosome procedure, ask for the exact product, its source and manufacturer, its FDA status in writing, how many sessions are planned, what result would count as success, and a written estimate. Individual results vary, and no result or duration is guaranteed.

Orlando considerations

Central Florida’s strong sun makes daily protection especially important after any procedure that resurfaces the skin, and the AAD calls sun protection essential for sun-damaged skin (AAD, 2025). Florida’s 2025 stem cell law lets physicians use certain non-FDA-approved stem cell therapies in orthopedics, wound care and pain management only, and its definition of cell and tissue products excludes secreted products such as “cell factors” (Fla. Stat. § 459.0127, 2025). That law does not make any exosome product FDA-approved, and it does not cover cosmetic facial use.

Frequently asked questions

Is an exosome facial the same as a stem cell facial?

Not necessarily. Exosome products contain no living cells. “Stem cell facial” is a marketing phrase that can describe plant extracts, cell-derived products or exosomes, so ask exactly what is in the vial and where it comes from.

Is exosome therapy for the face FDA-approved?

No. The FDA states there are currently no FDA-approved exosome products (FDA, 2019). Facial use is investigational.

How many sessions do people usually have?

There is no established number. Studies have often used a short series, such as three sessions two weeks apart (Choi et al., 2026). Your plan, if any, is set after an evaluation.

Are exosome serums from a store the same thing?

Not necessarily. Products vary widely in source and concentration, and a retail label usually does not say how much is inside. Results from clinical studies do not automatically apply to over-the-counter serums. If you try a new skincare product, patch-test it first.

References

  1. American Academy of Dermatology. (2025, October 30). How dermatologists treat sun-damaged skin. https://www.aad.org/public/everyday-care/sun-protection/sun-damage-skin/wrinkles-sun-damage-can-be-treated
  2. Choi, B. Y., Kim, H. J., Kim, M. J., Roh, Y. J., Hong, J. Y., Park, K. Y., & Sul, W. J. (2026). Adipose tissue-derived stem cell exosomes enhance skin barrier function and show exploratory associations with the skin mycobiome in aging skin. Journal of Microbiology, 64(6), e2603020. https://doi.org/10.71150/jm.2603020
  3. Dhaliwal, N. K., Moothathamby, T., Sokhal, B. S., & Gkini, M. A. (2026). The use of microneedling with exosomes in dermatology: A systematic review. Journal of Cosmetic Dermatology, 25(4), e70881. https://doi.org/10.1111/jocd.70881
  4. Fla. Stat. § 459.0127 (2025). Stem cell therapy. https://www.flsenate.gov/Laws/Statutes/2025/459.0127
  5. Flores Rodríguez, J. C., Toledo Avelar, L. E., Yi, K., Merino Arellano, R., López Rodríguez, J. A., & Garza Vargas, M. S. (2026). Efficacy of exosome-based therapies for skin rejuvenation: A systematic review of human studies. Cureus, 18(2), e104182. https://doi.org/10.7759/cureus.104182
  6. Huang, P. P., Chih, P. L., & OuYang, S. Y. (2026). Preliminary insights from a split-face study on skin quality changes after needling radiofrequency with or without a plant-derived exosome-based formulation over 6 months. Aesthetic Surgery Journal, 46, S62–S72. https://doi.org/10.1093/asj/sjaf253
  7. U.S. Food and Drug Administration. (2019, December 6). Public safety notification on exosome products. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products
  8. U.S. Food and Drug Administration. (2021, June 3; updated 2024, April 8). Important patient and consumer information about regenerative medicine therapies. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies

Medically reviewed by Kenny Chantasi, DO, on October 20, 2026. General education only; not a substitute for individual medical advice. No exosome product is FDA-approved for any use, including cosmetic use, and facial exosome procedures are considered investigational. Individual results vary, and no result or duration is guaranteed. Options are discussed only after an evaluation. In an emergency, call 911.

Talk it through with a physician.

An evaluation with Dr. Chantasi covers your history, your goals, and an honest view of what is likely to help — and what to skip.

Call More info Book a visit